Global NGS Market size to exceed $15 Billion by 2025

NGS Market size is set to exceed USD 15 billion by 2025; according to a new research report by Global Market Insights.
 

Research institutes and biotechnology companies undertakes extensive R&D activities that will foster demand for next generation sequencing instruments over the forecast timeframe. Academic as well as research institutes conduct R&D activities to understand cause and occurrence of certain genetic conditions. Scientists carry out detailed analysis of genome samples to develop the underlying cause and cure of such diseases. Availability of targeted sequencing and exosome sequencing techniques enable scientists to predict the exact cause and nature of genetic disease. Thus, adoption of such technologically advanced NGS instruments is high in the field of research that should augment NGS market growth in upcoming years.

 

Request Sample Buy NowInquiry Before Buying

 

Technological advancements in the field of next generation sequencing will drive the industry growth throughout the forecast period. Introduction of targeted sequencing panels have enabled analysis of specific mutations. Moreover, specificity of the NGS technology has improved speed and scalability of research processes. Upgradations in technology has allowed the researchers to assess multiple genes across several genome samples at a single time. Also, NGS techniques produce smaller sets of data and makes it manageable as compared to data generated by whole genome sequencing technique. Therefore, as the technology is evolving, more sophisticated NGS instruments are replacing the conventional proving beneficial for the industry growth. However, high cost of the NGS instruments may have negative impact on the industry growth.


NGS Market

Get more details on this report - Request Free Sample PDF
 

Clinical application segment was valued at USD 2 billion in 2018 and is projected to witness significant growth during the forecast years. Doctors and clinicians utilize NGS technology to predict the occurrence of several chronic diseases within individuals. Due to an increase in prevalence of hereditary diseases, adoption of WGS technique for studying the genome has elevated since past few years. According to Global Genes, 350 million people suffer from rare genetic disease globally that has positively impacted the demand for NGS technology driving segmental growth.
 

Exome sequencing segment is expected to have 20.7% growth throughout the analysis timeframe owing to its extensive usage in detecting genetic diseases. It is one of the most effective ways of identifying genetic variants. Exome sequencing is often utilized to detect mutations in the genes as well as identify novel genes by comparing the exomes from patients with similar features that makes the drug discovery process easy. Aforementioned factors are projected to elevate the segment growth.
 

Ion semiconductor sequencing segment accounted for 11.2% in 2018 and will grow significantly throughout the analysis period. Ion semiconductor technology is superior from other sequencing technologies in terms of efficiency and accuracy. Therefore, this technology is being extensively utilized in research, clinical and other research processes as it provides accurate analysis. It possess around 99.6% accuracy that elevates its adoption thereby, propelling the segment growth.
 

Research centers and academics segment is expected to show 21.3% growth during analysis timeframe. Stupendous segmental growth will be as a result of wide usage of NGS platform in various research studies. Academic institutes and research centers in developed economies undertake several experimental studies that involves analysis of genetic data at molecular level. Therefore, these academic institutes prefer technologically advanced NGS that are efficient and cost-effective that will stimulate the segment growth of next generation sequencing market in coming years.
 

Browse key industry insights spread across 135 pages with 148 market data tables & 10 figures & charts from the report, “Next Generation Sequencing Market Size By Product Type (Instruments, Consumables, Services), By Application (Research Application, Clinical Application {Cardiovascular, Reproductive Health, Cancer, Infectious Diseases}, Other Applications), By Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing), End-user (Academic Institutes & Research Centers,  Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, India, China, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/next-generation-sequencing-market
 

Asia Pacific NGS market held 20.2% revenue share in 2018 and regional market growth is driven by rising prevalence of genetic diseases. People have become aware regarding benefits of early detection of genetic diseases that should augment adoption of NGS instruments in hospitals. Also, industry players such as Illumina having a strong foothold in this region adopt several initiatives that supports development in the next generation sequencing techniques ensuring its adoption thereby, proving beneficial for the regional industry growth.


Few major industry players operating in the NGS market include Illumina, Thermo-Fisher, Roche, Pac-Bio, Long Read Solutions, BGI, Oxford Nanopore, Qiagen, Genapsys, BioRad, Agilent, NanoString, 10X Genomics. Chief industry players adopt various strategic initiatives such as mergers, acquisitions and new product launch that renders them with competitive advantage. For instance, in 2018, Illumina announced collaboration with KingMed Diagnostics develop NGS technology for hereditary disease testing and oncology that will extend company’s product portfolio and foster company’s growth.
 

Inquiry Before BuyingRequest Sample
 

Next generation sequencing market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

NGS Market, by Product Type (USD million)

  • Instruments
  • Consumables
  • Services

NGS Market, by Type (USD million)

  • Whole genome sequencing
  • Exome sequencing
  • Targeted sequencing
  • Others

NGS Market, by Application (USD million)

  • Research application
  • Clinical application
    • Cardiovascular
    • Reproductive health
    • Cancer
    • Infectious diseases
    • Others
  • Other applications

NGS Market, by Technology (USD million)

  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Other applications

NGS Market, by End-user (USD million)

  • Research centers & academics
  • Hospitals
  • Pharmaceuticals and biotechnology companies
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree